Dennis Podlesak

Track

Insider profile

Currently holds positions in Adynxx Inc and Syndax Pharmaceuticals, Inc.

Performance

Overall performance
3.0
Performance over holding periods
3.0
30 days 90 days 120 days
Average return 25% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chairman of the Board Adynxx Inc None -
Independent Chairman of the Board Syndax Pharmaceuticals, Inc. Dec. 1, 2008 -
Director Euthymics Bioscience Inc April 4, 2006 - Jan. 1, 2012
Dennis Podlesak's trades of Syndax Pharmaceuticals, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
343.19
Quantity 50,043
Value US$2,788,693
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-08-18 2025-08-18
PrS Proposed sale
50,043
343.19
US$2,788,693 		50,043 343.19 US$2,788,693
2025-08-18 2025-08-18
PlS Planned sale
10,462 -10.3%
316.16
US$4,833,748 		10,462 -10.3% 316.16 US$4,833,748
2025-08-18 2025-08-15
PlS Planned sale
824 +14.0%
127.88
US$3,785,813 		824 +14.0% 127.88 US$3,785,813
2025-08-18 2025-08-14
PlS Planned sale
19,200 -9.1%
14.19
US$272,521 		19,200 -9.1% 14.19 US$272,521
2025-08-14 2025-08-14
PrS Proposed sale
43,200
13.45
US$581,040 		43,200 13.45 US$581,040
2022-09-16 2022-09-16
PlS Planned sale
6,556 -8.0%
23.43
US$153,625 		6,556 -8.0% 23.43 US$153,625
2022-09-16 2022-09-16
PlS Planned sale
5,419 -6.7%
23.43
US$126,982 		5,419 -6.7% 23.43 US$126,982
2022-09-16 2022-09-15
PlS Planned sale
66,840 -46.9%
24.20
US$1,617,381 		66,840 -46.9% 24.20 US$1,617,381
2021-04-22 2021-04-22
B Purchase
13,967 +47.6%
14.11
US$197,077 		13,967 +47.6% 14.11 US$197,077